Breakthrough in Epilepsy Treatment: MRX-II and MRX-II-T

Ananda Developments Finance Director Jeremy Sturgess-Smith on the firm’s progress with its potential breakthrough Epilepsy treatments #EpilepsyTreatment #MRXII #ClinicalTrials #DrugResistance #NHS #Pharmaceuticals #InnovationInMedicine #HealthResearch #UCL #GreatOrmondStreetHospital